General Electric   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Schenectady NY United States (1892)
Status: Acquired by Danaher (2019)

Organization Overview

First Clinical Trial
2003
NCT00209391
First Marketed Drug
1951
iopanoic acid (telepaque)
First NDA Approval
1951
iopanoic acid (telepaque)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Canadian Heads of Academic Radiology-GE Healthcare Development Award | GEHC (Sponsor) | GE Healthcare | GE HEALTHCARE | GE Healthcare Bio-Sciences | GE HLTHCARE INC | GEN ELECTRIC | General Electric | General Electric Healthcare Life Sciences | Pharmaceutical Product Development, LLC